SHIRAKI Masataka | Department of Internal Medicine, Research Institute and Practice for Involutional Diseases

スポンサーリンク

概要

関連著者

もっと見る

著作論文

Association of a single nucleotide polymorphism in the constitutive androstane receptor gene with bone mineral density
Association of a single nucleotide polymorphism in the steroid and xenobiotic receptor (SXR) gene (IVS1-579A/G) with bone mineral density
Randomized trial comparing low-dose hormone replacement therapy and HRT plus 1α-OH-vitamin D_3 (alfacalcidol) for treatment of postmenopausal bone loss
Association of a single nucleotide polymorphism in the secreted frizzled-related protein 4 (sFRP4) gene with bone mineral density
Association of single nucleotide polymorphisms in the promoter region of the pro-opiomelanocortin gene (POMC) with low bone mineral density in adult women
Association of a single-nucleotide polymorphism in the promoter region of leukemia inhibitory factor receptor gene with low bone mineral density in adult women
A1330V Variant of the Low-density Lipoprotein Receptor-related Protein 5 (LRP5) Gene Decreases Wnt Signaling and Affects the Total Body Bone Mineral Density in Japanese Women
The synergistic effect of bone mineral density and methylenetetrahydrofolate reductase (MTHFR) polymorphism (C677T) on fractures
Association of a single nucleotide polymorphism in Wnt10b gene with bone mineral density
The sample size required for intervention studies on fracture prevention can be decreased by using a bone resorption marker in the inclusion criteria : prospective study of a subset of the Nagano Cohort, on behalf of the Adequate Treatment of Osteoporosis
A Placebo-Controlled, Single-Blind Study to Determine the Appropriate Alendronate Dosage in Postmenopausal Japanese Patients with Osteopotosis
Nonenzymatic collagen cross-links induced by glycoxidation (pentosidine) predicts vertebral fractures
Efficacy and tolerability of once-weekly administration of 17.5mg risedronate in Japanese patients with involutional osteoporosis : a comparison with 2.5-mg once-daily dosage regimen
Association of HTRA1 promoter polymorphism with spinal disc degeneration in Japanese women
Validation of the Japanese Osteoporosis Quality of Life Questionnaire
Bone mass effects of a Smad6 gene polymorphism in Japanese postmenopausal women
Association of a Single Nucleotide Polymorphism in the Insulin-Like Growth Factor-1 Receptor Gene With Spinal Disc Degeneration in Postmenopausal Japanese Women
Therapeutic effects of alendronate 35mg once weekly and 5mg once daily in Japanese patients with osteoporosis : a double-blind, randomized study
Bone metabolic marker levels in residents of a rural community in Japan
Effects of 2 Years' Treatment of Osteoporosis with 1α-Hydroxy Vitamin D3 on Bone Mineral Density and Incidence of Fracture : A Placebo-Controlled, Double-Blind Prospective Study
The Relationship Between Back Pain and Future Vertebral Fracture in Postmenopausal Women
Stability of [Asu1, 7]-Eel Calcitonin and Eel Calcitonin in Vitro and in Vivo
Immunological Stability in Vitro and in Vivo of Eel Calcitonin
Design of a pragmatic approach to evaluate the effectiveness of concurrent treatment for the prevention of osteoporotic fractures
Urinary pentosidine and plasma homocysteine levels at baseline predict future fractures in osteoporosis patients under bisphosphonate treatment

もっと見る

スポンサーリンク